Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $100 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky maintains an Outperform rating on Merit Medical Systems (NASDAQ:MMSI) with a $100 price target.
July 02, 2024 | 6:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research analyst Michael Petusky maintains an Outperform rating on Merit Medical Systems (NASDAQ:MMSI) with a $100 price target.
The reaffirmation of an Outperform rating and a $100 price target by Barrington Research is a positive signal for investors. It suggests confidence in the company's future performance, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100